Anti-biofilm Wound Dressing Market Size, Share & Trends Report

Anti-biofilm Wound Dressing Market Size, Share & Trends Analysis Report By Mode Of Mechanism (Physical, Chemical, Biological), By Application, By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2020 - 2027

  • Published Date: Aug, 2020
  • Base Year for Estimate: 2019
  • Report ID: GVR-4-68038-948-7
  • Format: Electronic (PDF)
  • Historical Data: 2015 - 2018
  • Number of Pages: 90

Report Overview 

The global anti-biofilm wound dressing market size was valued at USD 570.1 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 9.1% from 2020 to 2027. A worldwide increase in the incidence of chronic diseases such as cancer, diabetes, and other diseases is driving the market. Factors such as unhealthy and sedentary lifestyle, antimicrobial resistance, alcohol consumption, and smoking are contributing to the rising prevalence of non-communicable diseases. For instance, as per the studies conducted by B. Braun Melsungen AG in 2018, around 2.0% to 10.0% of diabetic people suffer from diabetic foot ulcers. In addition, as per the American College of Physicians, in 2017, the global annual incidence rate of diabetic foot ulcers is around 6.3% and the lifetime incidence rate of foot ulcers in patients suffering from diabetes ranges from 19.0%-34.0%. Since anti-biofilm wound dressing products are highly recommended for treating chronic injuries thus, this factor is expected to immensely boost the growth of the market. 

The U.S. anti-biofilm wound dressing market size

According to the U.S. CDC, 6 in 10 adults are suffering from a chronic disease and 4 in 10 adults are suffering from two or more chronic diseases in the U.S. Furthermore, chronic diseases are the leading cause of disability and death and the key contributor to the country’s USD 3.5 trillion annual healthcare costs. As a result of the rising prevalence of chronic conditions, the number of surgeries being performed has increased. Wound dressing products such as silver-based dressing are increasingly being used to prevent surgical site infections. Most surgical injuries after cancer surgery are generally large in size & deep, producing exudate that requires regular management. Anti-biofilm wound dressing products such as silver and iodine-based dressings help to manage large wounds, thus, reducing the risk of infection. Therefore, the rising incidence of chronic diseases is expected to boost the demand for the products, thereby propelling the growth of the market.

Increasing incidence of burns, trauma events, and road accidents across the globe is anticipated to drive the market for anti-biofilm wound dressing. For instance, according to WHO (2018), approximately 1,000,000 people in India suffer from severe or moderate burn every year. In addition, as per the NCBI, in 2017, countries such as Finland, the Netherlands, Bulgaria, China, Australia, and the U.K. reported a rise in the incidence of burn injuries. Furthermore, according to the American Association for the Surgery of Trauma, in 2017, around 1.2 million people died globally, and road accidents account for around 3,242 deaths per day. Road accidents mostly occur in middle- or low-income countries. Biomaterials and skin substitutes are majorly used for healing all kinds of burn injuries. Thus, a rising number of accidents is expected to boost the demand for first-aid products, which is expected to lead to considerable growth of the market over the forecast period.

Furthermore, as more people are participating in sports and recreational activities, the risk of injuries is increasing. For instance, according to Stanford Children’s Health, over 3.5 million injuries are reported annually among children and teens in the U.S., and around 21.0% of all injuries are traumatic brain injuries. Furthermore, according to the Canadian Institute for Health Information, from 2016 to 2017, around 17,655 people were hospitalized due to sports-related injuries. Similarly, according to the American Physical Therapy Association (APTA) 2017 report, approximately 8.6 million sports injuries are reported in the U.S. each year. Thus, an increase in the incidence of injuries is anticipated to drive the demand for anti-biofilm wound dressing products, thereby propelling the growth of the market.

Application Insights

The acute wounds segment held the largest revenue share of around 60.1% in 2019 in the market for anti-biofilm wound dressing. This is owing to the rising cases of burns and trauma and the increasing number of surgeries across the globe. An acute wound is an injury to the skin that occurs unexpectedly and includes incisions, abrasions, burns, scratches, and puncture injuries. It heals at a normal rate according to the regular injury healing process. These types of injuries can take place anywhere on the body and differ from small scratches to deep injuries. The acute wounds segment is further classified into surgical or traumatic wounds and burns wounds. Treating acute injuries will depend on the severity and location of the injury. However, the primary treatment includes, dressing of the injury and prevention against biofilm formation. Thus, the increasing number of patients suffering from an acute injury is expected to boost the growth of the market.

The chronic wounds segment is anticipated to witness the fastest growth in the market over the forecast period owing to the increasing cases of chronic diseases, especially diabetes, across the globe. Chronic or non-healing injuries occur when there is no significant healing of an injury for about 4 weeks. These types of injuries progress and will heal slower than expected or will not heal at all. The symptoms of chronic injuries include increased infection and pain in the area of injury. This can be due to pressure on or around the injury, exposure to bacteria or trauma, or insufficient blood and oxygen supply. It is estimated that 1%-2% of the population will suffer from a chronic injury once in their lifetime.

In the U.S., it is stated that chronic injuries affect around 6.5 million people. Moreover, the incidence of chronic injuries is expected to increase with aging and will impose a significant financial burden on society. It is estimated that more than USD 25.0 billion is spent by the healthcare system on treating wound-related complications every year in the U.S. In addition, as per the American Diabetes Association (ADA), more than 9-12 million people in America suffer from chronic ulcers. Thus, increasing cases of chronic diseases, especially diabetes, and rising geriatric population across the globe are the major drivers of the segment. These common injuries have different characteristics. There are many common types of chronic wounds. The chronic wound segment is further fragmented into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others.

Mode of Mechanism Insights

The chemical mode of mechanism segment held the largest revenue share of around 44.0% in 2019 in the market. The segment is anticipated to witness significant growth over the forecast period. This is owing to the rising prevalence of chronic injuries and an increasing number of surgeries across the globe. The chemical-based anti-biofilm wound dressing products allow multi-faceted action against biofilm, thereby increasing the healing rate and recovery efficiency of the chronic wounds. It also reduces the biofilm burden on both chronic and acute wounds and lowers the risk of acquiring recontamination with microorganisms. The chemical segment has been further segmented into ionic silver, iodine, EDTA, and others.

Global anti-biofilm wound dressing market share

The chemical mode of mechanism segment is anticipated to witness the fastest growth rate in the anti-biofilm wound dressing market over the forecast period. The presence of several players offering anti-biofilm wound dressing products with iodine and ionic silver is the major factors promoting segment growth. In addition, researchers are also taking initiatives to introduce advanced anti-biofilm wound dressing products in the market for better treatment of chronic and acute injuries. For instance, in June 2020, the National Biofilms Innovation Centre of the U.K. announced the grant of USD 28,949.03 to research and to introduce new product lines related to managing, engineering, and detecting biofilms. Therefore, all these factors are anticipated to positively impact the growth of the market over the forecast period.

Regional Insights

North America dominated the market in 2019 and accounted for a revenue share of 45.4% in 2019. The region is expected to witness a considerable CAGR of 9.1% over the forecast period. Increasing the incidence of sports injuries, the rising number of road accidents and the presence of several key players in the region are some of the factors expected to drive the market in the region. In addition, the presence of a highly developed healthcare infrastructure and favorable reimbursement policies are expected to propel market growth in the region over the forecast period.

In Asia Pacific, the market is anticipated to witness the fastest growth during the forecast period. The presence of developing countries such as Japan, India, and China is anticipated to fuel market growth in this region. In addition, the growing medical tourism industry in these countries is also contributing to the increasing demand for anti-biofilm wound dressing products in this region. For instance, according to a report on Export Health Services by Directorate-General of Commercial Intelligence and Statistics of India, in 2015-2016, India had 58,300 tourists on medical visas.

In Latin America, the market is anticipated to grow at a significant rate during the forecast period. The presence of developing economies, such as Brazil and Mexico, is expected to primarily drive the market in the region. The availability of advanced treatment options at low cost in Latin America is making the region a preferred destination for medical tourism. In addition, governments of countries in Latin America are consistently involved in improving healthcare infrastructure. Thus, such factors are expected to fuel the growth of the market in the region over the forecast period.

Key Companies & Market Share Insights

Key companies are stressing on research and development to develop technologically advanced products to gain a competitive edge. For instance, in January 2018, Imbed Biosciences raised a fund of around USD 1.6 million with an aim to introduce silver-based anti-biofilm wound dressing products, Microlyte Ag in the market, after the completion of their research on this product. Companies are engaging in partnerships, mergers, and acquisitions, aiming to strengthen their product portfolio, manufacturing capacities, and provide competitive differentiation. For instance, in April 2019, Smith and Nephew PLC announced the acquisition of Osiris Therapeutics, Inc., which specializes in regenerative medicine products. With this acquisition, the company will accelerate the development of its advanced wound management product portfolio, thereby expanding its customer pool and market reach. This initiative is anticipated to boost the growth of the company. Some of the prominent players in the anti-biofilm wound dressing market include:

  • ConvaTec

  • Smith & Nephew PLC

  • Urgo Medical

  • Coloplast

  • 3M

Anti-biofilm Wound Dressing Market Report Scope

Report Attribute

Details

Market size value in 2020

USD 616.8 million

Revenue forecast in 2027

USD 1.1 billion

Growth Rate

CAGR of 9.1% from 2020 to 2027

Base year for estimation

2019

Historical data

2015 - 2018

Forecast period

2020 - 2027

Quantitative units

Revenue in USD million and CAGR from 2020 to 2027

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Mode of mechanism, application, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

The U.S.; Canada; The U.K.; Germany; Japan; China; Brazil; Mexico; South Africa; Saudi Arabia

Key companies profiled

ConvaTec; Smith & Nephew PLC; Urgo Medical; Coloplast; 3M

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2027. For the purpose of this study, Grand View Research has segmented the global anti-biofilm wound dressing market report on the basis of mode of mechanism, application, and region:

  • Mode of Mechanism Outlook (Revenue, USD Million, 2015 - 2027)

    • Physical

      • Manual Debridement

      • Pulse Electrical Field

      • Ultrasound Debridement

    • Chemical

      • Ionic Silver

      • Iodine

      • EDTA

      • Others

    • Biological

      • Dispersin B

      • Lactoferrin

      • Bacteriophage

      • Others

  • Application Outlook (Revenue, USD Million, 2015 - 2027)

    • Chronic Wounds

      • Diabetic Foot Ulcers

      • Pressure Ulcers

      • Venous Leg Ulcers

      • Others

    • Acute Wounds

      • Surgical & Traumatic Wounds

      • Burn Wounds

  • Regional Outlook (Revenue, USD Million, 2015 - 2027)

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • The U.K.

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

Frequently Asked Questions About This Report

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPR norms. All interactions are confidential.

  • GDPR.EU
  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities